No Google (NASDAQ:
). No Apple (NASDAQ:
). No Amazon (NASDAQ:
) or Netflix (NASDAQ:
), either. Those technology and Internet darlings, along with
other noteworthy, similar U.S.-based fare, do not populate
with a heavy bias to the technology sector.
That has not been a problem this year as some emerging markets
have enjoyed stealth rallies
. These ETFs usually are not investors' first stopping point when
it comes to developing world investments, but the good news there
may be more upside in store.
Emerging markets technology shares not only trade at discounts
relative to more defensive sectors, the group is also home to
strong earnings momentum and could see some dividend increases
due to sturdy balance sheets,
Barron's reported last week, citing a UBS
Those positive catalysts could drive the following ETFs higher
EGShares Technology GEMS ETF (NYSE:
) The EGShares Technology GEMS ETF, which turns two in a few
weeks, may be an ETF that many investors have not heard of.
However, QGEM is home to several stocks U.S. investors are likely
familiar with, including Infosys (NYSE:
), Baidu (NASDAQ:
) and Sina (NASDAQ:
). Hint: China and India combine for almost 82 percent of this
Cozying up to QGEM means investors need to think outside of
the box a bit because the ETF is not large by assets, nor is it
heavily traded with average daily volume of just 380 shares.
Still, must be remembered that many of QGEM's holdings trade
millions of shares per day, either in the U.S., China or India or
Additionally, the ETF rarely trades at excessive premiums to
its net asset value. In the first quarter of this year, QGEM's
largest premium to NAV was just 0.48 percent,
according to issuer data
. QGEM is up 8.1 percent in the past month, a performance that
easily tops some of the more popular U.S.-focused tech ETFs.
iShares MSCI All Country Asia Information Technology Index
) The also small and thinly traded iShares MSCI All Country Asia
Information Technology Index Fund is not a pure play emerging
markets ETF as Japan garners a 34 percent weight. That is either
a good thing or a bad thing,
depending on the next move in Japanese stocks
Taiwan, South Korea and China combine for over 60 percent of
AAIT's weight. Two familiar names dominate this ETF with Samsung
and Taiwan Semiconductor (NYSE:
) combing for 29 percent of the total weight. Of the 87 remaining
stocks, none receive a weight above 5.1 percent.
AAIT has been a decent, though not spectacular performer in
recent weeks. That could be a sign that while the weak yen is
helping the ETF's Japanese holdings, the strong won is proving
problematic for the fund's South Korean constituents. Split that
difference, and the Taiwanese and Chinese holdings will have to
do the heavy lifting here.
Guggenheim China Technology ETF (NYSE:
) The Guggenheim China Technology ETF has surged 13.5 percent in
the past month, making it one of the top-performing China ETFs of
any stripe. NetEase (NASDAQ:
), Sina, Tencent and Baidu have been among the drivers of CQQQ's
bullish ways as that quartet combines for almost 29 percent of
the fund's weight.
CQQQ also underscores the notion that emerging market tech
names are not yet richly valued as the ETF has a P/E of just 12.5
and a price-to-book ratio of 1.8,
according to Guggenheim data
. The Guggenheim offering has a direct competitor in the form of
the Global X NASDAQ China Technology ETF (NASDAQ:
), though the former is larger, more heavily traded and recently
the better performer.
Another option for the investor craving exposure to Chinese
tech names without the commitment of an ETF entirely devoted to
one sector is the PowerShares Golden Dragon China Portfolio
). PGJ, which has $192.4 million in AUM, devotes almost 51
percent of its weight to tech stocks and nine of its top-10
holdings, including Baidu, Sina and Ctrip.com (NASDAQ:
), are tech or Internet stocks. PGJ is up 9.7 percent in the past
month and the fund offers decent exposure to discretionary and
health care names as well.
For more on ETFs, click
(c) 2013 Benzinga.com. Benzinga does not provide investment
advice. All rights reserved.
Profit with More New & Research
. Gain access to a streaming platform with all the information
you need to invest better today.
Click here to start your 14 Day Trial of Benzinga